Cheggour S, Georger F. [Remote monitoring of implantable monitors : Towards coverage ? Evaluation of the procedure by the French National Authority for Health].
Ann Cardiol Angeiol (Paris) 2021;
70:326-331. [PMID:
34629173 DOI:
10.1016/j.ancard.2021.09.002]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 09/02/2021] [Indexed: 06/13/2023]
Abstract
Implantable cardiac monitors are recommended and reimbursed in two specific cases: the etiological diagnosis of unexplained recurrent syncope and the etiological diagnosis of a cryptogenic ischemic stroke. According to the French National Authority for Health (HAS), remote monitoring "leads to early diagnosis and therapeutic care". However, remote tracking of these devices for diagnostic purposes is not included in the ETAPES program, which will end soon. This article presents a summary of the evaluation by HAS of the remote monitoring of implantable cardiac monitors. It also addresses the question of its reimbursement, as for therapeutic implantable devices.
Collapse